Table 2.
PVI in cancer patients.
| Study (year) | Mean Age (year) | Male n (%) | History of Cancer/Active Cancer n | Type of Tumor (%) | Type of Arrhythmia n (%) | Procedure Length (min) | Adverse Event (n) |
Restoration of Sinus Rhythm after Ablation n | Follow Up (Year) |
|---|---|---|---|---|---|---|---|---|---|
| Kanmanthareddy et al. (2015) [63] | 63 ± 7 | 10 (100) | 10 | Not specified | Atrial fibrillation (AF) 15 (100) | 200 ± 33 | Groin hematoma (2) | 12 | 1 |
| Shabtaie et al. (2021) [64] | 62.4 ± 9.3 | 9 (53) | 17 | Neuroendocrine tumors (100) | Atrial flutter 2 (11.7) AF 4 (23.5) Atrioventricular nodal reentrant tachycardia 7 (41.2) Premature ventricular contractions 3 (17.6) Ventricular Tachycardia 1 (5.9) |
196.4 ± 108.5 | Deep venous thrombosis (1) Cardiac tamponade (1) access site bleeding A1) |
2 | 1.6 ± 2.2 |
| Giustozzi et al. (2021) [65] | 64.3 ± 7.5 | 14 (67) | 21 | Solid tumors (95.2) Haematologic tumor (4.8) |
AF 21 (100) | Not specified | Clinically relevant bleedings (4) Peri-procedural thromboembolic event (1) |
13 | 0.08 ± 0.013 |
| Eitel et al. (2021) [66] | 71.3 ± 8.3 | 39 (55.7) | 70 | Genitourinary cancer (30), breast cancer (28.6), haemato-oncologic cancer (12.9), gastrointestinal cancer (11.4), head or neck cancer (5.7), lung cancer (2.9) | AF 7 (100), | 128.7 ± 36.1 | Phrenic nerve palsy (4) Pseudoaneurysm (2) |
47 * | 1.68 ± 0.97 |
| Ganatra et al. (2020) [67] | 65.5 | 81 (50) | 162 | Breast cancer (30.8) Other types of cancer (69.2) |
AF 162 (100) | Not specified | Access site bleeding (5) Non-access site bleeding (4) strokes (2) Cardiac tamponade (2) pulmonary vein stenosis (1) |
133 * | Not specified |
AF: Atrial Fibrillation. * Referred to the first year of follow up.